"Does it feel like Fuji walked out of the hook up with Cynata"
You do feel some funny things Ledge.
This is positive for Cynata, a large pharma turning to iPSC starting material/ manufacturing...and why wouldn't you compared to sucking out bone marrow.....from multiple donors
You obviously have a poor understanding of the Cymerus process. and as usual, that poor knowledge base breeds misinformation.
"iPSCs themselves are not administered directly to patients as medical treatments. Instead, the iPSCs are used as a starting material to produce other types of cells, which may have the potential to be used as therapeutic agents. In Cynata’s case, iPSCs are used in the manufacture of its Cymerus™ mesenchymal stem cells (MSCs)."
CYP Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)